MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-UP-01-0037364
Perfocon Pharma Private Limited
Perfocon Pharma Private Limited - pharma in Agra, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹6.24 Cr
▼ 10% YoY
Net profit · FY 2025
₹23.34 Lakh
Net margin 3.7%
EBITDA · FY 2025
₹58.91 Lakh
EBITDA margin 9.4%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹7.5 Lakh
Issued & subscribed
Open charges
₹2 Cr
Satisfied ₹2 Cr
Company age
8 yrs
Est. 2018
Employees · EPFO
7
Provident fund records
About Perfocon Pharma Private Limited
Data last updated:
Perfocon Pharma Private Limited is a private limited company based in Agra, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 02 November 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U51909UP2018PTC110035. Its GSTIN is 09AAKCP1852A1ZL (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹7.5 Lakh. It was formerly known as Perfocon Solutions Private Limited. It is led by directors including Anjul Agarwal and Suchita Mittal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Room No. 2 2nd Floor Fortune Tower Sector 9 Awas Vikas Colony Sikandra, Agra, Uttar Pradesh, India – 282007.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.24 Cr, a decline of 10% compared to the previous year. For the same year it recorded a net profit of ₹23.34 Lakh (net margin 3.7%) and EBITDA of ₹58.91 Lakh (EBITDA margin 9.4%). Revenue has grown at a compounded annual rate (CAGR) of 48% over three years.
The company has about 7 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹2 Cr and satisfied charges of ₹2 Cr on record.
Perfocon Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-01-0037364).
Company details
CIN U51909UP2018PTC110035
Registration Number 110035
Incorporation Date 02 November 2018
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Small
Udyam Registration UDYAM-UP-01-0037364
Recognitions & Rankings of Perfocon Pharma
Contact details
Perfocon Pharma Private Limited's registered office is in Agra, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressRoom No. 2 2nd Floor Fortune Tower Sector 9 Awas Vikas Colony Sikandra, Agra, Uttar Pradesh, India – 282007
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Perfocon Pharma Private Limited, buy the company report.
Comprehensive company report
Perfocon Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Perfocon Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Perfocon Pharma Private Limited, buy the company report.
Financials of Perfocon Pharma Private Limited
FY 2025 filings availablePerfocon Pharma Private Limited reported revenue of ₹6.24 Cr (down 10% YoY) for FY 2025.
Revenue · FY 2025
₹6.24 Cr ▼ 10%
Net profit · FY 2025
₹23.34 Lakh margin 3.7%
EBITDA · FY 2025
₹58.91 Lakh margin 9.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 10%
3 years · compounded
▲ 48%
EBITDA CAGR growth
1 year
▼ 50%
3 years · compounded
▲ 90%
Revenue fell 10% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 48%. EBITDA fell 50% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹6.24 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹58.91 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹23.34 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.4% | ||||
| Net Profit Margin | 3.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Perfocon Pharma Private Limited, buy the company report.
Board of directors of Perfocon Pharma Private Limited
Perfocon Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anjul Agarwal | Director | 02 Nov 2018 | 7 Years 11 Months | Current |
| Suchita Mittal Also directs: Rachil Remedies Pvt Ltd, Lumicon Solutions Private Limited | Director | 02 Nov 2018 | 7 Years 11 Months | Current |
| Kumkum Mittal | Director | 04 Oct 2021 | 5 Years 0 Months | Current |
Peer comparison
Perfocon Pharma Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Hi-Tec Laboratories Pvt. Ltd. | ₹6.25 Cr (FY 2025) | 1.0% | Patna, Bihar, India | |||
| Bhandaree Consumer Products Private Limited | ₹6.25 Cr (FY 2025) | 139.0% | Mumbai, Maharashtra, India | |||
| Sach Pharmatech Private Limited | ₹6.24 Cr (FY 2025) | 41.0% | Delhi, India | |||
| 6Ipain Healthcare Private Limited | ₹6.24 Cr (FY 2024) | -20.0% | Delhi, India | |||
| Perfocon Pharma Private Limitedthis company | ₹6.24 Cr (FY 2025) | ₹23.34 Lakh | 3.7% | -10.0% | 7 | Agra, Uttar Pradesh, India |
| Horn Bill Pet Needs Private Limited | ₹6.23 Cr (FY 2024) | -13.0% | Bangalore, Karnataka, India | |||
| Ursapharm India Private Limited | ₹6.22 Cr (FY 2024) | -23.0% | New Delhi, Delhi, India |
To see the full peer comparison of Perfocon Pharma Private Limited, buy the company report.
Auditor
Perfocon Pharma Private Limited is audited by Ajay Parmanand & Co for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Ajay Parmanand & Co | FY 2024 | 020292C |
Shareholding
The shareholding of Perfocon Pharma Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Perfocon Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2 Cr
Satisfied charges
₹2 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 May 2024 | 100938771 | Axis Bank Limited | ₹2 Cr | Satisfied |
To see the full charge records of Perfocon Pharma Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Perfocon Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Perfocon Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Perfocon Pharma Private Limited has a workforce of 7 employees on its EPFO records as of Jan 28, 2025, across 1 active EPFO establishment.
Employee count
7
Active EPFO establishments
1
Employee growth
16.67%
GST
Perfocon Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAKCP1852A1ZL | Uttar Pradesh | Active | 04 Jan 2019 |
To see the full GST registrations and return filing status of Perfocon Pharma Private Limited, buy the company report.
Recent activity
Perfocon Pharma Private Limited has 5 board changes on record since 2018: 3 appointments and 2 cessations. The latest: Kumkum Mittal ceased to be Additional Director on 25 Nov 2021.
AGM
Perfocon Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge registered on 31 May 2024 via Charge ID 100938771 with Axis Bank Limited was fully satisfied on 08 Sep 2025.
Filing
Perfocon Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Charges
A charge with Axis Bank Limited amounted to Rs. 200.00 Lakh with Charge ID 100938771 was registered on 31 May 2024.
Ceased
Kumkum Mittal ceased to be Additional Director.
Appointed
Kumkum Mittal was appointed as Director.
Ceased
Yash Jaggi ceased to be Director.
Appointed
Anjul Agarwal was appointed as Director.
Appointed
Suchita Mittal was appointed as Director.
Incorporation
02 Nov 2018
Perfocon Pharma Private Limited was registered on 02 Nov 2018 with Roc Kanpur & aged 7 years 11 months as per MCA records.
Frequently asked questions
Perfocon Pharma is an active private limited company based in Agra, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 02 November 2018 (8+ years old) and is registered under CIN U51909UP2018PTC110035.
Perfocon Pharma has 3 current directors:
- Anjul Agarwal - Director
- Suchita Mittal - Director
- Kumkum Mittal - Director
The latest financial statements of Perfocon Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Perfocon Pharma is 09AAKCP1852A1ZL, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Perfocon Pharma is U51909UP2018PTC110035. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Perfocon Pharma was incorporated on 02 November 2018, making it 8+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Perfocon Pharma by revenue are Hi-Tec Laboratories Pvt. Ltd, Bhandaree Consumer Products Private Limited, Sach Pharmatech Private Limited, 6Ipain Healthcare Private Limited, Horn Bill Pet Needs Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Kumkum Mittal ceased to be Additional Director on 25 Nov 2021. Kumkum Mittal was appointed as Director on 04 Oct 2021. Yash Jaggi ceased to be Director on 17 Aug 2020. Perfocon Pharma has 5 board changes on record in total.
Yes, Perfocon Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-UP-01-0037364).
The registered office of Perfocon Pharma is at Room No. 2 2nd Floor Fortune Tower Sector 9 Awas Vikas Colony Sikandra, Agra, Uttar Pradesh, India – 282007.
Perfocon Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.